BG102182A - The use of ipriflavon for reducing the number of cd8+ cells - Google Patents
The use of ipriflavon for reducing the number of cd8+ cellsInfo
- Publication number
- BG102182A BG102182A BG102182A BG10218298A BG102182A BG 102182 A BG102182 A BG 102182A BG 102182 A BG102182 A BG 102182A BG 10218298 A BG10218298 A BG 10218298A BG 102182 A BG102182 A BG 102182A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ipriflavon
- cells
- reducing
- selectivesuppression
- isopropoxyisophalon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
PCT/HU1996/000038 WO1997003664A1 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Publications (1)
Publication Number | Publication Date |
---|---|
BG102182A true BG102182A (en) | 1998-08-31 |
Family
ID=10987063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102182A BG102182A (en) | 1995-07-21 | 1998-01-14 | The use of ipriflavon for reducing the number of cd8+ cells |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0841915A1 (hu) |
JP (1) | JP2001503371A (hu) |
KR (1) | KR19990028933A (hu) |
CN (1) | CN1191483A (hu) |
AR (1) | AR002905A1 (hu) |
AU (1) | AU6367096A (hu) |
BG (1) | BG102182A (hu) |
BR (1) | BR9610187A (hu) |
CA (1) | CA2227421A1 (hu) |
CZ (1) | CZ2798A3 (hu) |
EA (1) | EA199800146A1 (hu) |
EE (1) | EE9800020A (hu) |
HR (1) | HRP960345A2 (hu) |
HU (1) | HU9502198D0 (hu) |
IL (1) | IL122751A0 (hu) |
MX (1) | MX9800603A (hu) |
NO (1) | NO980127L (hu) |
PL (1) | PL324460A1 (hu) |
SK (1) | SK3298A3 (hu) |
WO (1) | WO1997003664A1 (hu) |
YU (1) | YU42796A (hu) |
ZA (1) | ZA966079B (hu) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1241079B (it) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico |
HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/hu unknown
-
1996
- 1996-07-16 EE EE9800020A patent/EE9800020A/xx unknown
- 1996-07-16 EA EA199800146A patent/EA199800146A1/ru unknown
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/cs unknown
- 1996-07-16 CN CN96195722A patent/CN1191483A/zh active Pending
- 1996-07-16 MX MX9800603A patent/MX9800603A/es unknown
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 IL IL12275196A patent/IL122751A0/xx unknown
- 1996-07-16 BR BR9610187A patent/BR9610187A/pt not_active Application Discontinuation
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/ko not_active Application Discontinuation
- 1996-07-16 PL PL96324460A patent/PL324460A1/xx unknown
- 1996-07-16 JP JP50646497A patent/JP2001503371A/ja active Pending
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 SK SK32-98A patent/SK3298A3/sk unknown
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/xx unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/hr not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/sh unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/es unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127L/no unknown
- 1998-01-14 BG BG102182A patent/BG102182A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HRP960345A2 (en) | 1998-02-28 |
IL122751A0 (en) | 1998-08-16 |
EE9800020A (et) | 1998-08-17 |
NO980127D0 (no) | 1998-01-12 |
EP0841915A1 (en) | 1998-05-20 |
HU9502198D0 (en) | 1995-09-28 |
PL324460A1 (en) | 1998-05-25 |
CZ2798A3 (cs) | 1998-06-17 |
MX9800603A (es) | 1998-04-30 |
KR19990028933A (ko) | 1999-04-15 |
AR002905A1 (es) | 1998-04-29 |
SK3298A3 (en) | 1998-07-08 |
JP2001503371A (ja) | 2001-03-13 |
NO980127L (no) | 1998-01-12 |
EA199800146A1 (ru) | 1998-08-27 |
CN1191483A (zh) | 1998-08-26 |
YU42796A (sh) | 1999-03-04 |
WO1997003664A8 (en) | 1999-08-05 |
WO1997003664A1 (en) | 1997-02-06 |
AU6367096A (en) | 1997-02-18 |
CA2227421A1 (en) | 1997-02-06 |
ZA966079B (en) | 1998-01-19 |
BR9610187A (pt) | 1998-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA928771B (en) | Combination chemotherapy | |
UA37244C2 (uk) | Спосіб лікування або профілактики клінічних розладів, виліковних прогестероном, у пацієнтів жіночої статі | |
IL76932A0 (en) | Pharmaceutical compositions containing dihydrocodeine and ibuprofen | |
AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
ITMI922953A1 (it) | Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono. | |
ZA874635B (en) | Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation | |
AU7554087A (en) | Pharmaceutical composition with analgesic activity | |
EG18379A (en) | Novel pharmacological compounds | |
EP1535929A3 (en) | Megakaryocyte stimulating factors | |
AU7672587A (en) | Compositions for parenteral administration and their use | |
MC1915A1 (fr) | Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant | |
EP0663835A1 (en) | USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS. | |
IL81833A0 (en) | Renin inhibitors,their preparation and pharmaceutical compositions containing them | |
NZ230155A (en) | N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions | |
BE902796A (fr) | Ester d'acetyl carnitine, sa preparation et son utilisation. | |
IL83412A (en) | 5',5'-disubstituted 2',5'-dideoxyuridines and 2',5'-dideoxycytidines,their preparation and pharmaceutical compositions containing them | |
BG102182A (en) | The use of ipriflavon for reducing the number of cd8+ cells | |
AU7439996A (en) | Novel uses of mammalian ctla-8 and related reagents | |
AU2798689A (en) | Oral dosage units for pharmaceuticals and their use and preparation | |
ES8704903A1 (es) | Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido. | |
EP0371733A3 (en) | Dopamine-beta-hydroxylase inhibitors | |
IL80733A0 (en) | 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same | |
AU576473B2 (en) | Spiro(2h-1,4-benzodioxepin-3(5h)4'-piperidine and 3'- pyrrolidino) compounds | |
MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it |